Verified Document

Healthcare Legislation And Economic Competition Research Paper

Antitrust Legislation and Healthcare The Sherman Anti-Trust Act (1890) was designed to promote competitive practices in the marketplace and protect consumers from price gouging and other egregious practices generated from a lack of competition in monopolistic markets. It was not originally designed to impact the healthcare market but over the years its protections have been extended to do so

Strengths

Antitrust and anticompetitive laws were not always applied to physician and healthcare conduct. But in Goldfarb v. Virginia State Bar (1975), the “Supreme Court made it clear that professional conduct that interfered with normal market processes would face a heavy burden of justification and might even be unlawful per se” (Sage, Hyman, & Greenberg, 2003, par. 18). This ensured that collusion between healthcare providers, including withholding information, was illegal. It also meant that it was illegal to limit the actions of consumer ratings agencies which graded physicians and other healthcare providers. This was deemed to be necessary to the free flow of information needed for commercial activity. Antitrust laws are thus designed to promote transparency as well as consumer choice, given that transparency is necessary for a competitive economic system to flourish.

Weaknesses

Perhaps unsurprisingly, physicians have been largely opposed...

Parts of this document are hidden

View Full Document
svg-one

Physicians believe that collaboration between providers, healthcare agencies, and other regulatory organizations will improve rather than inhibit delivery of quality services. “Suppose a payer approaches you and several of your colleagues, who are competitors. The payer gives you a contract and fee schedule that you review with your colleagues’ (Cohen, 2003, par. 5). Physicians state that as professionals, reviewing such contracts between themselves could facilitate rather than inhibit better patient care.
On the other hand, critics of the Sherman Antitrust Act state that it has not done enough to protect consumers. In many healthcare markets, there are relatively few providers, which substantially limits consumer choice. Also, under current law, consumers cannot purchase healthcare policies across state lines and even the healthcare exchanges under the Affordable Care Act (ACA) are limited by state. Also, the limits upon government regulation to merely curtail a lack of competition does not address issues such as spiraling drug price costs, given that the federal government cannot cap drug prices (Chamseddine, 2015).

Opportunities

Given the recent passage of the Affordable Care Act (ACA) and calls for reform, there are hopes the legislative climate is…

Sources used in this document:

References

Chamseddine, J. (2015). Obamacare, antitrust laws can coexist, says FTC official.

Washington Health Policy Week in Review. Retrieved from: http://www.commonwealthfund.org/publications/newsletters/washington-health-policy- in-review/2015/dec/dec-21-2015/obamacare-antitrust-laws-can-coexist

Cohen, J. (2012). How antitrust laws hinder the goals of healthcare reform. Medical Economics.

Retrieved from: http://medicaleconomics.modernmedicine.com/medical- economics/news/modernmedicine/modern-medicine-now/how-antitrust-laws-hinder- goals-healthcare?page=full

Sage, W., Hyman, D. & Greenberg, W. (2003). Why competition law matters to healthcare

quality. Health Affairs, 22(2) 31-44. Retrieved from:

http://content.healthaffairs.org/content/22/2/31.full

 

Cite this Document:
Copy Bibliography Citation

Sign Up for Unlimited Study Help

Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.

Get Started Now